Lipid levels

Lipid levels refer to the concentrations of various lipids—primarily cholesterol and triglycerides—in the blood. These measurements include low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol, and triglycerides. Lipid levels are not themselves molecular targets but rather *clinical biomarkers* used to assess cardiovascular and metabolic health. They serve as key indicators for the diagnosis, monitoring, and management of diseases such as dyslipidemia, cardiovascular disease, diabetes mellitus, metabolic syndrome, and neurodegenerative disorders like Alzheimer’s disease. Therapeutic interventions—including statins, PCSK9 inhibitors, fibrates, ezetimibe—are designed to modify these lipid parameters by targeting specific enzymes or receptors involved in lipid metabolism; however, "lipid levels" themselves do not represent a single druggable molecule or receptor. Therefore, "lipid levels" is not an appropriate entry for a therapeutic target database—it is too broad and refers to measurable outcomes rather than discrete biological entities. Lowering LDL-C is considered the primary target in lipid-lowering strategies for reducing cardiovascular risk; however this refers specifically to lowering the concentration of LDL particles in plasma—not targeting “lipid levels” as an entity. In summary: “Lipid levels” are *not* a canonical molecular target but rather aggregate clinical measurements reflecting underlying biological processes. For structured data on therapeutic targets related to blood lipids you should instead specify individual molecules such as “Low-density lipoprotein receptor,” “Proprotein convertase subtilisin/kexin type 9,” “HMG-CoA reductase,” etc.

Other names

Lipid profileBlood lipidsSerum lipid levelsPlasma lipid levels